Global Oligonucleotide Synthesis Market Size, Status, Research and Forecast 2019-2025

Published On: Jul 2019

Format: PDF

Publisher: QY Research

Pages: 107

Report ID: 3882

Oligonucleotide synthesis is the chemical synthesis of relatively short fragments of nucleic acids with defined chemical structure (sequence). The technique is extremely useful in current laboratory practice because it provides a rapid and inexpensive access to custom-made oligonucleotides of the desired sequence.
Oligonucleotides find a variety of applications in molecular biology and medicine. They are most commonly used as antisense oligonucleotides, small interfering RNA, primers for DNA sequencing and amplification, probes for detecting complementary DNA or RNA via molecular hybridization, tools for the targeted introduction of mutations and restriction sites, and for the synthesis of artificial genes.
In 2018, the global Oligonucleotide Synthesis market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Oligonucleotide Synthesis status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Oligonucleotide Synthesis development in United States, Europe and China.

The key players covered in this study
Integrated DNA Technologies
Merck KGaA
Eurofins Genomics
Thermo Fisher Scientific
Bioautomation
Agilent Technologies
Eurogentec
GE Healthcare
LGC Biosearch Technologies
Nitto Denko Avecia
Genscript
Genedesign
TriLink Biotechnologies
Bio-Synthesis
ATDBio

Market segment by Type, the product can be split into
Synthesized Oligonucleotides
Reagents
Equipment

Market segment by Application, split into
PCR
DNA
RNAi
Research
Therapeutic

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Oligonucleotide Synthesis status, future forecast, growth opportunity, key market and key players.
To present the Oligonucleotide Synthesis development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Oligonucleotide Synthesis are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Oligonucleotide Synthesis Market Size Growth Rate by Type (2014-2025)
1.4.2 Synthesized Oligonucleotides
1.4.3 Reagents
1.4.4 Equipment
1.5 Market by Application
1.5.1 Global Oligonucleotide Synthesis Market Share by Application (2014-2025)
1.5.2 PCR
1.5.3 DNA
1.5.4 RNAi
1.5.5 Research
1.5.6 Therapeutic
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Oligonucleotide Synthesis Market Size
2.2 Oligonucleotide Synthesis Growth Trends by Regions
2.2.1 Oligonucleotide Synthesis Market Size by Regions (2014-2025)
2.2.2 Oligonucleotide Synthesis Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Oligonucleotide Synthesis Market Size by Manufacturers
3.1.1 Global Oligonucleotide Synthesis Revenue by Manufacturers (2014-2019)
3.1.2 Global Oligonucleotide Synthesis Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Oligonucleotide Synthesis Market Concentration Ratio (CR5 and HHI)
3.2 Oligonucleotide Synthesis Key Players Head office and Area Served
3.3 Key Players Oligonucleotide Synthesis Product/Solution/Service
3.4 Date of Enter into Oligonucleotide Synthesis Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Oligonucleotide Synthesis Market Size by Type (2014-2019)
4.2 Global Oligonucleotide Synthesis Market Size by Application (2014-2019)

5 United States
5.1 United States Oligonucleotide Synthesis Market Size (2014-2019)
5.2 Oligonucleotide Synthesis Key Players in United States
5.3 United States Oligonucleotide Synthesis Market Size by Type
5.4 United States Oligonucleotide Synthesis Market Size by Application

6 Europe
6.1 Europe Oligonucleotide Synthesis Market Size (2014-2019)
6.2 Oligonucleotide Synthesis Key Players in Europe
6.3 Europe Oligonucleotide Synthesis Market Size by Type
6.4 Europe Oligonucleotide Synthesis Market Size by Application

7 China
7.1 China Oligonucleotide Synthesis Market Size (2014-2019)
7.2 Oligonucleotide Synthesis Key Players in China
7.3 China Oligonucleotide Synthesis Market Size by Type
7.4 China Oligonucleotide Synthesis Market Size by Application

8 Japan
8.1 Japan Oligonucleotide Synthesis Market Size (2014-2019)
8.2 Oligonucleotide Synthesis Key Players in Japan
8.3 Japan Oligonucleotide Synthesis Market Size by Type
8.4 Japan Oligonucleotide Synthesis Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Oligonucleotide Synthesis Market Size (2014-2019)
9.2 Oligonucleotide Synthesis Key Players in Southeast Asia
9.3 Southeast Asia Oligonucleotide Synthesis Market Size by Type
9.4 Southeast Asia Oligonucleotide Synthesis Market Size by Application

10 India
10.1 India Oligonucleotide Synthesis Market Size (2014-2019)
10.2 Oligonucleotide Synthesis Key Players in India
10.3 India Oligonucleotide Synthesis Market Size by Type
10.4 India Oligonucleotide Synthesis Market Size by Application

11 Central & South America
11.1 Central & South America Oligonucleotide Synthesis Market Size (2014-2019)
11.2 Oligonucleotide Synthesis Key Players in Central & South America
11.3 Central & South America Oligonucleotide Synthesis Market Size by Type
11.4 Central & South America Oligonucleotide Synthesis Market Size by Application

12 International Players Profiles
12.1 Integrated DNA Technologies
12.1.1 Integrated DNA Technologies Company Details
12.1.2 Company Description and Business Overview
12.1.3 Oligonucleotide Synthesis Introduction
12.1.4 Integrated DNA Technologies Revenue in Oligonucleotide Synthesis Business (2014-2019)
12.1.5 Integrated DNA Technologies Recent Development
12.2 Merck KGaA
12.2.1 Merck KGaA Company Details
12.2.2 Company Description and Business Overview
12.2.3 Oligonucleotide Synthesis Introduction
12.2.4 Merck KGaA Revenue in Oligonucleotide Synthesis Business (2014-2019)
12.2.5 Merck KGaA Recent Development
12.3 Eurofins Genomics
12.3.1 Eurofins Genomics Company Details
12.3.2 Company Description and Business Overview
12.3.3 Oligonucleotide Synthesis Introduction
12.3.4 Eurofins Genomics Revenue in Oligonucleotide Synthesis Business (2014-2019)
12.3.5 Eurofins Genomics Recent Development
12.4 Thermo Fisher Scientific
12.4.1 Thermo Fisher Scientific Company Details
12.4.2 Company Description and Business Overview
12.4.3 Oligonucleotide Synthesis Introduction
12.4.4 Thermo Fisher Scientific Revenue in Oligonucleotide Synthesis Business (2014-2019)
12.4.5 Thermo Fisher Scientific Recent Development
12.5 Bioautomation
12.5.1 Bioautomation Company Details
12.5.2 Company Description and Business Overview
12.5.3 Oligonucleotide Synthesis Introduction
12.5.4 Bioautomation Revenue in Oligonucleotide Synthesis Business (2014-2019)
12.5.5 Bioautomation Recent Development
12.6 Agilent Technologies
12.6.1 Agilent Technologies Company Details
12.6.2 Company Description and Business Overview
12.6.3 Oligonucleotide Synthesis Introduction
12.6.4 Agilent Technologies Revenue in Oligonucleotide Synthesis Business (2014-2019)
12.6.5 Agilent Technologies Recent Development
12.7 Eurogentec
12.7.1 Eurogentec Company Details
12.7.2 Company Description and Business Overview
12.7.3 Oligonucleotide Synthesis Introduction
12.7.4 Eurogentec Revenue in Oligonucleotide Synthesis Business (2014-2019)
12.7.5 Eurogentec Recent Development
12.8 GE Healthcare
12.8.1 GE Healthcare Company Details
12.8.2 Company Description and Business Overview
12.8.3 Oligonucleotide Synthesis Introduction
12.8.4 GE Healthcare Revenue in Oligonucleotide Synthesis Business (2014-2019)
12.8.5 GE Healthcare Recent Development
12.9 LGC Biosearch Technologies
12.9.1 LGC Biosearch Technologies Company Details
12.9.2 Company Description and Business Overview
12.9.3 Oligonucleotide Synthesis Introduction
12.9.4 LGC Biosearch Technologies Revenue in Oligonucleotide Synthesis Business (2014-2019)
12.9.5 LGC Biosearch Technologies Recent Development
12.10 Nitto Denko Avecia
12.10.1 Nitto Denko Avecia Company Details
12.10.2 Company Description and Business Overview
12.10.3 Oligonucleotide Synthesis Introduction
12.10.4 Nitto Denko Avecia Revenue in Oligonucleotide Synthesis Business (2014-2019)
12.10.5 Nitto Denko Avecia Recent Development
12.11 Genscript
12.12 Genedesign
12.13 TriLink Biotechnologies
12.14 Bio-Synthesis
12.15 ATDBio

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details